 |
市場調查報告書
商品編碼
1672801
全球骨髓移植市場按類型、治療類型、最終用戶和地區分類Bone Marrow Transplant Market, By Type, By Treatment Type, By End User, By Geography |
||||||
價格
簡介目錄
2025 年全球骨髓移植市場規模預估為 112 億美元，預計到 2032 年將達到 152.6 億美元，2025 年至 2032 年的複合年成長率為 4.5%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 112億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年複合年成長率： | 4.50％ | 2032 年價值預測 | 152.6億美元 |
數字。 2025 年骨髓移植市場佔有率（%），依地區分類
骨髓移植是將健康的骨髓幹細胞注入患者體內以取代受損或不健康的骨髓的過程。骨髓移植常用於治療多種血癌，包括白血病、淋巴瘤和其他血液疾病。幹細胞可以從患者（自體移植）或捐贈者（同種異體移植）獲得。同種異體移植比自體移植的成功率更高，因為捐贈的幹細胞可以產生健康的新細胞。然而，由於免疫排斥，併發症的風險也更高。移植程序的進步和與捐贈者匹配的改善導致了對骨髓移植的巨大需求。
市場動態：
全球骨髓移植市場的成長是由全球血癌和其他血液疾病發生率的上升所推動的。根據世界衛生組織發布的資料，2018年全球通報的癌症新病例約1,810萬，癌症死亡病例約960萬。此外，人們對移植作為有效替代療法的認知不斷提高，對免疫抑制劑研發的投資不斷增加，正在推動市場的發展。然而，移植手術的高成本、兼容捐贈者的有限性以及移植後移植排斥的風險可能會阻礙市場的成長。此外，採用周邊血幹細胞作為骨髓替代療法也阻礙了市場的成長。幹細胞療法的發展很可能在不久的將來為市場進入者提供豐厚的機會。
本研究的主要特點
- 本報告對全球骨髓移植市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和複合年成長率。
- 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 全球骨髓移植市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球骨髓移植市場報告涵蓋了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員將透過用於分析全球骨髓移植市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第 4 章。全球骨髓移植市場：COVID-19 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
第 5 章。全球骨髓移植市場按類型分類（2020-2032 年）
- 自體移植
- 同種異體移植
- 其他
6. 全球骨髓移植市場依治療類型分類（2020-2032 年）
- 白血病
- 淋巴瘤
- 骨髓瘤
- 骨髓發育不良症候群
- 骨髓增生性疾病
- 再生障礙性貧血
- 固態腫瘤
- 鐮狀細胞性貧血
- 地中海型貧血
- 其他
7. 全球骨髓移植市場以最終用戶分類（2020-2032 年）
- 醫院
- 多專科診所
- 門診手術中心
8. 全球骨髓移植市場按地區分類（2020-2032 年）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- 公司簡介
- Merck Millipore Corporation
- Sanofi-Aventis LLC.
- AllCells LLC.
- STEMCELL Technologies
- ATCC Inc.
- Hemacare Corporation
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
第 10 章分析師建議
- 命運之輪
- 分析師觀點
- Coherent Opportunity Map（COM）
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI232
Global Bone Marrow Transplant Market is estimated to be valued at USD 11.20 Bn in 2025 and is expected to reach USD 15.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11.20 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.50% | 2032 Value Projection: | USD 15.26 Bn |
Figure. Bone Marrow Transplant Market Share (%), By Region 2025
Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged or unhealthy bone marrow of a patient. It is commonly used for treating various blood cancers like leukemia, lymphoma and other blood disorders. The stem cells can either be obtained from the patient (autologous transplant) or from a donor (allogeneic transplant). Allogeneic transplants have shown more success rates as compared to autologous as the donated stem cells can produce healthy new cells. However, it also carries higher risks of complications due to immune rejection. With advancements in transplant procedures and better donor matching, there has been huge demand for bone marrow transplants.
Market Dynamics:
Global bone marrow transplant market growth is driven by rising prevalence of blood cancers and other hematological disorders worldwide. According to the data published by WHO, around 18.1 million new cancer cases and 9.6 million cancer deaths were reported in 2018 globally. Furthermore, growing awareness about transplantation as an effective treatment alternative and increasing investment in research & development of immunosuppressant drugs are driving the market growth. However, high costs associated with transplant procedures, limited availability of matched donors, and risks of graft rejection post-transplant can hamper the market growth. Adoption of peripheral blood stem cells as an alternative to bone marrow can also hamper the market growth. The development of stem cell therapies can offer lucrative opportunities for market players in the near future.
Key Features of the Study:
- This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bone marrow transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AllCells, ReachBio LLC, Conversant Bio, Cellular Dynamics International, and Takeda Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market
Detailed Segmentation-
- By Type
- Autologous Transplant
- Allogenic Transplant
- Others
- By Treatment Type
- Leukemia
- Lymphoma
- Myeloma
- Myelodysplastic Syndrome
- Myeloproliferative Disorders
- Aplastic Anemia
- Solid Tumors
- Sickle cell Anemia
- Thalassemia
- Others
- By End User
- Hospitals
- Multi-specialty Clinics
- Ambulatory Surgical Centers
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck Millipore Corporation
- Sanofi-Aventis LLC.
- AllCells LLC.
- STEMCELL Technologies
- ATCC Inc.
- Hemacare Corporation
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bone Marrow Transplant Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bone Marrow Transplant Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Autologous Transplant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allogenic Transplant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Bone Marrow Transplant Market, By Treatment Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myeloma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myelodysplastic Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myeloproliferative Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Aplastic Anemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Solid Tumors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sickle cell Anemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thalassemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Bone Marrow Transplant Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Multi-specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Bone Marrow Transplant Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Merck Millipore Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi-Aventis LLC.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AllCells LLC.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STEMCELL Technologies
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ATCC Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hemacare Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
- Merck Millipore Corporation
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
"
